Fatalities associated with gabapentinoids in England (2004–2020)

The gabapentinoids were reclassified as Schedule II medications and Class C drugs in the UK in 2019 due to their potential misuse. In this study we examined deaths following gabapentinoid use in England reported to the National Programme on Substance Abuse Deaths. A total of 3051 deaths were reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalk, Nicola J., Chiu, Ching‐Ting, Sadoughi, Rasa, Baho, Heli, Williams, Bryn D., Taylor, David, Copeland, Caroline S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543893/
https://www.ncbi.nlm.nih.gov/pubmed/35435281
http://dx.doi.org/10.1111/bcp.15352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543893/
https://www.ncbi.nlm.nih.gov/pubmed/35435281
http://dx.doi.org/10.1111/bcp.15352

Ejemplares similares